Islet amyloid polypeptide is the major protein component of the islet amyloid of patients with Type 2 (noninsulin-dependent) diabetes mellitus. Since the synthesis of a structurally abnormal or mutant protein may contribute to the formation of amyloid deposits, we have examined the possibility that a mutant form of islet amytoid polypeptide or its precursor contributes to the formation of islet amyloid in Type 2 diabetic patients. We have sequenced the islet amyloid polypeptide precursor coding regions of the gene of 25 patients with Type 2 diabetes. Genomic DNA fragments corresponding to exon 2 and 3 of the islet amyloid polypeptide gene were amplified from patients' peripheral blood leucocyte DNAs using the polymerase chain reaction and specific oligonucleotide primer sets, and then directly sequenced. The nucleotide sequences of the amplified regions of both alleles of the islet amyloid polypeptide gene of these 25 patients were identical to one another and to the sequence of an islet amyloid polypeptide allele isolated from a human fetal liver genomic library. These findings suggest that a primary structural abnormality of islet amyloid polypeptide or its precursor is unlikely to play a significant role in the formation of islet amyloid in Type 2 diabetic patients.
The presence of amyloid deposits is one of the most characteristic morphological features of the islets of Langerhans of patients with Type 2 (non-insulin-dependent) diabetes mellitus [1] . Amyloid deposits are also present in the islets of aged individuals although the extent of involvement is less than occurs in diabetic subjects. In addition, islet amyloid is associated with some insulinomas [2] . A major protein component of islet amyloid is islet amyloid polypeptide (IAPP) or amylin, a 37 amino acid carboxyamidated hormone-like peptide that is structurally related to the calcitonin gene-related peptides [3, 4] . The morphological data and preliminary physiological data suggest that islet amyloid and/or IAPP may be responsible for impaired Beta cell function and peripheral insulin resistance in Type 2 diabetes [5] .
The characterization of the fibrillar proteins present in the amyloid deposits associated with other disorders of localized as well as systemic amyloidosis has shown that the synthesis of a structurally abnormal or mutant protein can contribute to the formation of amyloid deposits [6] . Although the amino acid sequence of human IAPP determined directly from protein isolated from insulinomas [3] and diabetic pancreas [4] was identical to that predicted from the sequences of both cDNA [7] and genomic clones [8] , it is possible that the synthesis of a variant form of the IAPP precursor contributes to the formation of islet amyloid. In order to examine this possibility and to determine the degree of sequence variation in the human IAPP gene, we have sequenced the IAPP precursor encoding regions of 25 Type 2 diabetic patients.
Subjects and methods
Twenty-five unrelated Type 2 diabetic patients were studied. These included 13 African-Americans, 10 Caucasians, one Pima Indian (individual 4011) and one affected individual from the RW Pedigree (individual 1246) -a large family with maturity-onset diabetes of the young (MODY) [9] . The diagnosis of Type 2 diabetes was made according to the recommendations of the National Diabetes Data Group.
Amplification of the IAPP gene and direct sequencing
Amplification of genomic DNA and followed by direct sequencing was carried out essentially as described by Kadowaki et al. [10] . Genomic DNA fragments corresponding to exons 2 and 3 of the . After incubation at 50 ~ for 40 min the reaction was terminated by adding 3 gl of stop solution (95% formamide, 20 mmol/1 EDTA, 0.05% bromophenoI blue and 0.05% xylene cyanol FF). The samples were analysed by electrophoresis through a 5% polyacrylamide and 8 tool/1 urea gel. After electrophoresis, the gel was dried and autoradiographed. 
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Results and discussion
Using the sequence of the h u m a n I A P P gene [8] as a guide, we selected primers that allowed the protein coding region of exons 2 and 3 of h u m a n I A P P gene to be amplified by P C R (Fig. 1, 2) . The analysis of the P C R products by gel electrophoresis indicated that little non-specific priming occurred (Fig. 2) . The sequences of the amplified region corresponding to both alleles of the I A P P gene of 25 Type 2 diabetic patients were identical to one another and to the sequence of the cloned gene. Thus, it is unlikely that a primary structural abnormality of I A P P or its precursor plays a significant role in the formation of islet amyloid. Since the sequences of 50 alleles of the I A P P gene were determined, the frequency of mutations in I A P P or its precursor in Type 2 diabetes patients is likely to be less than 2%. These data suggest that the high incidence of islet amyloid in Type 2 diabetes may result from the increased expression and/or abnormal production, process-ing or secretion of IAPP or its precursor rather than the synthesis of a structurally abnormal protein. In this regard, mutations in the promoter region of the IAPP gene of diabetic patients could result in abnormal regulation of its expression thereby leading to excessive IAPP secretion.
